Le LÚzard
Classified in: Health
Subjects: CCA, FVT

NuVasive to Participate in Investor Events in September 2020

SAN DIEGO, Aug. 31, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following virtual investor events in September:

A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. A replay of the presentations will remain available on the website for 30 days after the live webcast.

NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes access, implants and fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,800 employees and operates in more than 50 countries serving surgeons, hospitals and patients.áFor more information, please visitáwww.nuvasive.com.

Forward-Looking Statements
NuVasiveácautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could causeáNuVasive'sáresults to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use ofáNuVasive'sáproducts (including the iGA« platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described ináNuVasive'sánews releases and periodic filings with theáSecurities and Exchange Commission.áNuVasive'sápublic filings with theáSecurities and Exchange Commissionáare available atáwww.sec.gov.áNuVasiveáassumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

SOURCE NuVasive, Inc.

These press releases may also interest you

at 09:48
The Rheumatoid Arthritis marketáreport delivers an in-depth understanding of the Rheumatoid Arthritis, historical and forecasted epidemiology as well as the Rheumatoid Arthritis market trends in the United States, EU5 (Germany, France, Italy, Spain,...

at 09:47
Massage Envy,áthe nation's No. 1 provider of massage and skin care services in the U.S. across its franchise network, today announcedáits franchisees have donated over 2,300 one-hour services during the Coronavirus pandemic to healthcare...

at 09:45
Learning technology provider Meridian Knowledge Solutions today announced that Benco Dental has selected Meridian LMS to manage learning for their new customer education program. Benco Dental is the largest privately owned, full-service distributor...

at 09:43
Many Americans have changed their day-to-day habits due to the coronavirus pandemic, and some of those habits can have serious health implications. ValuePenguin's latest survey has found that 1 in 4 Americans are sleeping less, while 1 in 5 are...

at 09:30
According to the new market research report "Real-Time Location Systems Market (RTLS)áfor healthcare with COVID-19 Impact Analysis by Offering (Hardware, Software, Services), Technology (RFID, W-Fi, UWB, BLE, IR, Ultrasound, Others), Facility Type,...

at 09:30
Therapeutics Solution International, Inc., , announced today publication on the NIH clinical trials website1 of its newly initiated trial aiming to validate a blood-based diagnostic for predicting suicide risk.á The Campbell Scoretm, which is a...

News published on 31 august 2020 at 16:03 and distributed by: